Technion Research & Development Foundation Limited (Israel)
Inventor
Attias, Noam
Grobman, Jacob
Abitbol, Tiffany
Abstract
A method of preparing a composition comprising mycelium along with a cellulose and/or plurality of nanoparticles is described herein. The method comprises inoculating a liquid medium with fungus, the liquid medium comprising nutrients and the cellulose and/or nanoparticles. Further described herein are compositions comprising mycelium along with a cellulose and/or plurality of nanoparticles, as well as articles-of-manufacture comprising such a composition, wherein at least 10% of the cellulose and/or nanoparticles in the composition is incorporated within the mycelium. A method of enhancing fungal growth is also described, comprising contacting the fungus with a liquid medium comprising a polymer which comprises carboxylic acid groups.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
THE UNIVERSITY OF TOKYO (Japan)
Inventor
Brik, Ashraf
Kamnesky, Guy
Suga, Hiroaki
Huang, Yichao
Rogers, Joseph
Abstract
The present invention provides cyclic peptides, as well as methods of using the same, such as for ameliorating or treating a K63Ub-related disease in a subject in need thereof.
Technion Research & Development Foundation Limited (Israel)
MEDICAL RESEARCH & DEVELOPMENT FUND FOR HEALTH SERVICES, BNAI-ZION MEDICAL CENTER (Israel)
Inventor
Freiman, Mordechay Pinchas
Hanania, Eyal
Cohen, Israe
Abstract
A method for quantitative magnetic resonance imaging (MRI), the method includes (a) receiving a sequence of MRI images of an in vivo tissue, by an image registration deep neural network (DNN) module that was trained, by a training process, to impose one or more MRI signal related physical constraints on a content of the sequence of MRI images; and (b) extracting one or more quantitative map from the sequence of MRI images.
B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (Israel)
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Nir, Oded
Chaudhary, Mohit
Lahav, Ori
Nativ, Paz
Abstract
This invention relates to a device comprising polyethylene sulfone (PES) and additional suitable polymers with high load of Prussian blue analogue nanoparticles for removal of monovalent or divalent cation contaminants, optionally doped, and process for the preparation and methods for use thereof. The device and method relate to selectively and effectively remove ammoniacal nitrogen removal and recovery as a valuable resource, and removing radioactive cesium and/or other monovalent or divalent cations from contaminated water.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Bercovici, Moran
Elgarisi, Mor
Frumkin, Valeri
Luria, Omer
Abstract
A system and a method of fabricating an article are disclosed. The method comprises: providing an immersion liquid to at least one first portion and at least one second portion of a chamber divided by a divider; opening a valve between the at least one first and at least one second portions; providing a curable liquid to an article frame included in the divider; closing the valve; adjusting a volume or pressure of the immersion liquid in the at least one first portion using a pump, to control a curvature of the article; and curing the curable liquid to form the article.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Schroeder, Avraham
Abel, Ravit
Abstract
The present invention is directed to compositions comprising the Ag2S quantum dots of the invention and to methods for use thereof, such as for the treatment and/or prevention a cell or tissue damage and/or a disease or condition in a subject associated therewith. Further, pharmaceutical or cosmetic compositions comprising Ag2S quantum dots of the invention, and articles (e.g. cosmetic/medical article) comprising same are also provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (Israel)
RAMBAM HEALTH CORPORATION (Israel)
Inventor
Landesberg, Amir
Tsibulsky, Yakov
Rispler, Shmuel
Abstract
A method including sensing local accelerations or changes in sensor position, including orientation and displacement, with a local acceleration sensor mounted on a chest or abdomen of a patient, and calculating energy of polyphasic motions, based on sensed information of the local acceleration sensor and classifying severity of cardiac decompensation by calculating an excessive energy index (EEi) that compares excessive energy that appears in the polyphasic motions to energy required for inspiration at a basic respiratory rate.
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/08 - Measuring devices for evaluating the respiratory organs
A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
A61B 5/113 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb occurring during breathing
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
9.
SYSTEM OF PROTEIN-PROTEIN INTERACTION AND METHODS OF USING SAME
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Daniel, Ramez
Samuel, Roee
Habib, Mouna
Abstract
The present invention provides a system for direct protein-protein interaction between a first cell and a second cell, including: (a) a first cell including a first polynucleotide sequence encoding a first synthetic polypeptide being a membrane anchored ligand including an extracellular portion being a ligand domain and a first membrane anchoring domain; and (b) a second cell including: (i) a second polynucleotide sequence encoding a second synthetic polypeptide being a receptor including an extracellular portion being a binding domain having specific binding affinity to the ligand of (a), a second membrane anchoring domain, and an intracellular portion including a transcription factor; and (ii) a third polynucleotide sequence encoding a gene of interest. Further provided are methods of using the system, and a kit for preparing same.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Sacks, Rafael
Wang, Zijian
Ouyang, Boyuan
Abstract
The present invention relates generally to the technological field of computer-aided design and modeling. In the general aspect, the invention may be directed to a method of federated computer-aided modeling of an object, by at least one processor, the method including: obtaining a plurality of sub-models, complementary representing the object, wherein each sub-model consists of one or more structural elements defined by parameters thereof; for each sub-model, generating a sub-graph representation, having said structural elements and parameters thereof represented as semantic triples; analyzing said semantic triples taken from different sub-graph representations to detect interrelations therebetween; instantiating semantic connections between the generated sub-graph representations, based on detected interrelations, thereby obtaining a meta-graph representation of a model of the object; and developing the model of the object, based on the obtained meta-graph representation.
G06F 30/13 - Architectural design, e.g. computer-aided architectural design [CAAD] related to design of buildings, bridges, landscapes, production plants or roads
G06F 30/27 - Design optimisation, verification or simulation using machine learning, e.g. artificial intelligence, neural networks, support vector machines [SVM] or training a model
11.
REEXPRESSION OF HNF4A TO ALLEVIATE CANCER-ASSOCIATED CACHEXIA
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Erez, Ayelet
Goldman, Omer
Hajaj, Emma
Schroeder, Avi
Abstract
Methods of predicting clinical outcome in a subject suffering from cancer, detecting non-liver cancer in a subject, and methods of treating or preventing cancer or cancer-associated cachexia are provided. Synthetic lipid nanoparticles encapsulating an mRNA encoding for HNF4A and composition comprising same are also provided.
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
C07K 16/24 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
12.
MECHANOPHORIC MATRICES AND METHODS OF PREPARING SAME
Technion Research & Development Foundation Limited (Israel)
Inventor
Grolman, Joshua M.
Liao, Yifan
Zhang, Hang
Diesendruck, Charles Eliezer
Abstract
Mechanophoric compounds featuring one or more, or two or more, clickable group(s), which are capable of being coupled to naturally occurring, synthetic and/or metallic substrates via Click chemistry, method of preparing mechanophoric matrices using the mechanophoric compounds, and mechanophoric matrices obtainable thereby, and uses thereof for detecting force-induced damage in the matrices by a colorimetric change are provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Amit, Roee
Vaknin, Inbal
Abstract
Nucleic acid molecules configured to constitutively express a sequence of interest in a eukaryotic cell comprising a transcription factor binding region, a core promoter and a sequence of interest operatively linked to the transcription factor binding region and core promoter are provided. Methods of constitutively expressing a sequence of interest in a eukaryotic cell are also provided.
Technion Research & Development Foundation Limited (Israel)
Inventor
Balanov, Amnon
Kaminer, Ido
Abstract
An X-ray generator is presented comprising: an electron source generating an accelerated electron beam propagating along a first propagation path with a first general propagation direction; a first crystalline structure located in the first propagation path, and defining a first crystal plane oriented at a predetermined non-zero angle with the first propagation path, and configured to transmit the electron beam therethrough and generate parametric x-ray (PXR) emission being first directional emission along a second propagation path tilted with respect to the first general propagation direction; and a second crystalline structure located in the second propagation path and configured as a monochromator with respect to the PXR emission, and defining a second crystal plane oriented at the predetermined non-zero angle with respect to the second propagation path to thereby provide second directionality for the PXR emission.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Landesberg, Amir
Maiorov, Ida
Abstract
The present invention relates to a method and system for monitoring cardiac functions and quantifying objective, operator-independent indices of cardiac functions. The invention quantifies both ventricle cavity and wall dynamics. It provides a picture with a comprehensive view of the six phases of cardiac contraction, relaxation and filling (isovolumic contraction, ejection, isovolumic relaxation, rapid filling, diastasis and atrial kick). It enables to quantify the effect of respiration and mechanical ventilation on cardiac chamber loadings and thereby to optimize mechanical ventilation in the general and cardiac intensive care units. It enables to assess the phase differences between the electrical activations and mechanical contractions of the various chambers and thus to adjust and optimize the parameters of cardiac synchronization therapies of ventricle chambers and chamber walls (as cardiac resynchronization therapy).
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Khamaysi, Iyad
Hadad, Salim
Abassi, Zaid
Abstract
The invention relates generally to the field of compositions including one or more conjugates of di-sugar and a nonsteroidal anti-inflammatory drug (NSAID), and use of same in methods for treating a disease or a disorder in a subject in need thereof.
A61K 31/405 - Indole-alkanecarboxylic acidsDerivatives thereof, e.g. tryptophan, indomethacin
A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K 31/196 - Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
17.
SYSTEMS AND METHODS FOR IDENTIFICATION OF IONS IN SOLUTION
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Manor, Ofer
Aremanda, Sudeepthi
Abstract
The present invention relates to systems for identifying one or more ions in a liquid solution, including a solid surface configured to be in contact with the liquid solution; a mechanical wave generator configured to be in contact with the solid surface and/or with the liquid solution; and a working microelectrode configured to be positioned in the liquid solution in close proximity to the solid surface without contacting it. Methods of the invention include generating a mechanical wave which propagates and excites ions of an electrical double layer (EDL) formed at an interface between the solid surface and the liquid solution, thereby causing the EDL to vibrate and to leak an electrical field. The electrode measures electrical potential of the electrical field over time, which yields a voltage spectrum comprising amplitude and phase which are indicative of an identity and a concentration of the one or more ions in the liquid solution.
G01N 29/024 - Analysing fluids by measuring propagation velocity or propagation time of acoustic waves
G01N 29/22 - Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic wavesVisualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object Details
G01N 27/66 - Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosolsInvestigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electric discharges, e.g. emission of cathode using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber and measuring current or voltage
Technion Research & Development Foundation Limited (Israel)
Inventor
Sagi, Yoav
Abstract
An atomic interferometer system comprises optical tweezers each configured to trap at least one atom therein, an atom source system configured to release atoms, and a controller configured to control the optical tweezers to trap at least one atom released by the atom source system in one of the tweezers, to spatially split a wave function of the trapped atom between at least two of the tweezers, and to at least partially recombine the split atomic wave function in at least one of the tweezers. The atomic interferometer system can also comprise a measuring system configured to measure wavefunction population in each of the tweezers and to display an output pertaining to the wavefunction populations.
G01V 7/02 - Measuring gravitational fields or wavesGravimetric prospecting or detecting Details
G16C 10/00 - Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like
G21K 1/00 - Arrangements for handling particles or ionising radiation, e.g. focusing or moderating
H03L 7/26 - Automatic control of frequency or phaseSynchronisation using energy levels of molecules, atoms, or subatomic particles as a frequency reference
19.
DEGRADABLE POLYMERIC COMPOSITIONS AND ARTICLES COMPRISING SAME
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Davidovich-Pinhas, Maya
Rosen Kligvasser, Jasmine
Abstract
The present invention provides a composition comprising (i) a cellulose-based polymer, and (ii) a plasticizer; wherein a weight per weight (w/w) concentration of the plasticizer within the composition is from 0.1 to 20%; and wherein a glass transition temperature (Tg) of the composition is reduced by at least 20% compared to a Tg of the cellulose-based polymer. Furthermore, provided herein are articles comprising the composition of the invention, and methods for manufacturing thereof.
Technion Research & Development Foundation Limited (Israel)
Inventor
Priebe, Gregory P.
Kishony, Roy
Chung, Hattie
Schaefers, Matthew M.
Abstract
This disclosure relates to methods and compositions useful for detecting and monitoring low-frequency mutations. Methods and compositions described herein can be used to guide clinical decisions, for example, by informing on which antibiotics should be avoided, or conversely, which antibiotics should be actively used in the case of compounds that select against a specific type of resistance.
C12Q 1/689 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Vogt, Charlotte
Zisser Gal, Noam
Karo, Noam
Mayraz, Or
Licht, Assaf
Abstract
Nanostructured electrodes comprising nanoparticles of conductive material deposited on a conductive electrode support are described in the present invention. Said nanoparticles are characterised by a particle size of about 20.0 nm or less and a particle size distribution having a tuneable standard deviation from ±0.1 nm to ±1.0 nm. This particle size distribution is measured using a differential mobility analyser. The nanostructured electrodes are manufactured by the method of spark ablation, which provides a scalable and viable way for producing widely different types of mixed nanoparticles. Most importantly, implementation of the spark ablation has the great advantage to combine a wider range of materials, thereby allowing the synthesis of mixed nanoparticles with virtually unlimited combinations and highly sharp particle size distribution control which is advantageous for high tunability of selectivity.
B22F 9/14 - Making metallic powder or suspensions thereofApparatus or devices specially adapted therefor using physical processes using electric discharge
C02F 1/46 - Treatment of water, waste water, or sewage by electrochemical methods
C02F 1/461 - Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
C02F 1/66 - Treatment of water, waste water, or sewage by neutralisationTreatment of water, waste water, or sewage pH adjustment
C25B 1/04 - Hydrogen or oxygen by electrolysis of water
C25B 11/052 - Electrodes comprising one or more electrocatalytic coatings on a substrate
C25B 11/054 - Electrodes comprising electrocatalysts supported on a carrier
C25B 11/091 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds
C25B 13/07 - DiaphragmsSpacing elements characterised by the material based on inorganic materials based on ceramics
Technion Research & Development Foundation Limited (Israel)
Inventor
Sharon, Simon
Boader, Idan
Shoham, Moshe
Cohen, Eran
Morag, Eyal
Abstract
An assembly for driving linear movement and roll movement of an elongate surgical tool, comprising: an elongate shaft comprising a central lumen extending along the shaft long axis; the elongate shaft comprising a plurality of apertures extending across walls of the elongate shaft and into the central lumen; a set of wheels positioned opposing each other and aligned on two sides of the central lumen, the set of wheels at least partially extending through the apertures beyond the walls of the elongate shaft and into the central lumen to contact an elongate surgical tool received therein; the set of wheels being coupled to the elongate shaft and configured to rotate with the elongate shaft as a single unit when the elongate shaft is rotated about the shaft long axis.
A61B 1/00 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor
A61B 17/00 - Surgical instruments, devices or methods
A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
Technion Research & Development Foundation Limited (Israel)
Inventor
Pourati, Ryan
Larianovsky, Pavel
Ben Tur, Arnon
Grobman, Jacob
Shaked, Tom
Sprecher, Aaron
Weissman, Aharon
Masri, Bassam
Abstract
Disclosed is a method of fabricating a construction element. The method may include assembling a mold on a rotational casting machine; rotating the mold around at least two axes at a predetermined speed; providing a first portion of magnesium silico-phosphate cement (MSPC) mix, having an altered hardening rate, to the mold while rotating the mold until at least a portion of the mold's walls is covered by a first layer of the MSPC mix; and rotating the mold until the MSPC mix is hardened to a predetermined degree.
B28B 1/20 - Producing shaped articles from the material by centrifugal or rotational casting
C04B 20/00 - Use of materials as fillers for mortars, concrete or artificial stone according to more than one of groups and characterised by shape or grain distributionTreatment of materials according to more than one of the groups specially adapted to enhance their filling properties in mortars, concrete or artificial stoneExpanding or defibrillating materials
C04B 28/34 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
Technion Research & Development Foundation Limited (Israel)
Inventor
Diskin, David
Tartakovsky, Leonid
Abstract
A hybrid system, including a solid-oxide fuel cell (SOFC), an internal combustion engine (ICE), and a thermochemical recuperation (TCR) unit. The TCR unit is configured to: (i) receive waist heat from the ICE, (ii) receive a primary fuel, (iii) perform a waste heat recovery process to provide reformed fuel. The SOFC is configured to receive a first part of the reformed fuel and convert the first part of the reformed fuel to electrical work. The ICE is configured to receive a second part of the reformed fuel and convert the second part of the reformed fuel to mechanical work.
Technion Research & Development Foundation Limited (Israel)
Inventor
Machluf, Marcelle
Bronshtein, Tomer
Abstract
Compositions comprising liposomes composed of whole cell membrane fraction are provided. The liposomes may be attached to, or encapsulate a pharmaceutical agent. Also provided are methods of generating and using these liposomes.
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
29.
METHOD OF DETERMINING FUSOGENIC POTENTIAL OF SPERM AND USE THEREOF IN ASSISTED FERTILIZATION AND DRUG SCREENING
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Podbilewicz, Benjamin
Brukman, Nicolas Gaston
Valansi, Clari
Abstract
A method of determining fusogenic potential of sperm is provided, The method comprising: (a) contacting a biological sample comprising sperm with somatic cells expressing ectopic JUNO under conditions which allow binding of the sperm to the JUNO; and subsequently (b) detecting multinucleation in the somatic cells, wherein a level of the multinucleation is indicative of the fusogenic potential of the sperm.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
RAMBAM MED-TECH LTD. (Israel)
Inventor
Caspi, Oren
Haim, Idan Refael
Kazma, Noam
Abstract
An isolated multicellular organoid comprising cardiomyocytes, endothelial cells, fibroblasts and smooth muscle cells is disclosed. The endothelial cells form part of a 3D endothelial structure, the cardiomyocytes of the organoid are capable of synchronized contractions, and epicardial cells of the organoid do not form a distinct layer in the organoid. Methods of maturing immature cardiomyocytes and use of cardiomyocytes for generating disease models are also disclosed.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Haick, Hossam
Abstract
The disclosure provides a programmable, battery-less, autonomous and biodegradable smart dust particle (SDP) comprises: (i) a single layer or plurality of layers of a layered separating media for chromatographic separation of compounds contained in a sample subjected to the separation and for providing physical support for embedded electronics and for at least one detector; (ii) said at least one detector comprising an array of sensors printed on the layers of said separating media, and providing information on the presence and properties of said compounds in the sample; (iii) said embedded electronics printed on the layers of said separating media; and (iv) at least one radio-frequency identification (RFID) out-input tag for remote readout and zero-power operation, each RFID tag connected to said embedded electronics via an electric circuit for receiving or transmitting a signal. In addition, two systems comprising a plurality of the SDPs are disclosed: the first for autonomous analysis of an environmental sample and the second for tumour diagnosis. A method for diagnosing tumours and a wearable tomography device using the SDPs are also disclosed.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Kvatinsky, Shahar
Hodisan, Sariel
Abstract
A device for signal acquisition, comprises a transimpedance amplifier having an input receiving a current from an input device, an output to supply an output voltage reflective of the current; and a memristor component connected in a feedback path of the transimpedance amplifier, the memristor component transitioning between a high resistive state and a low resistive state depending on a voltage difference across the memristor component. The gain of the transimpedance amplifier is reduced as the increase in current approaches a saturation level of the amplifier and triggers the transition. The result is an increase in dynamic range of the transimpedance amplifier to better match the range of current output that may be expected from say an optical input device.
Technion Research & Development Foundation Limited (Israel)
Rambam Med-Tech Ltd. (Israel)
Inventor
Rolls, Asya
Gepstein, Lior
Haykin, Hedva
Azulay-Debby, Hilla
Abstract
Provided is reward system activation for therapeutic purposes. Accordingly there is provided a method of treating a disease in a subject in need thereof, the method comprising subjecting the subject to a treatment module which activates the reward system of the subject.
A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
34.
A METHOD AND SYSTEM FOR DETECTION AND ANALYSIS OF CHEMICAL COMPOUNDS IN A SAMPLE SUBJECTED TO A CHROMATOGRAPHIC SEPARATION ON A LAYERED SEPARATING MEDIUM
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Haick, Hossam
Maity, Arnab
Abstract
A method and system in the present invention allow to detect and analyse chemical compounds in a sample subjected to chromatographic separation on a layered medium. The system comprises a detector comprising an array of sensors printed on each layer of the separating medium, and providing information on the presence and properties of the tested compounds in the sample. The machine-learning methods used in the method of the invention are shown to be the methods of choice when analysing the spectrometry data, for example μGC data, in a variety of scenarios and in a variety of applications, including real-time molecular analysis. These machine-learning methods can effectively learn the spectroscopic and chromatographic models taking into account various kinetic and thermodynamic parameters and by that constitute an advantageous alternative to traditional spectroscopic and chromatographic analytical methods.
H05K 1/16 - Printed circuits incorporating printed electric components, e.g. printed resistor, capacitor, inductor
H05K 3/12 - Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using printing techniques to apply the conductive material
35.
METHODS AND COMPOSITIONS FOR USE IN IMPROVING ADAPTIVE IMMUNITY IN THE ELDERLY POPULATION
Technion Research & Development Foundation Limited (Israel)
Inventor
Ron-Harel, Noga
Ezuz, David
Abstract
A method of increasing proliferation of adaptive immune cells of a subject at least 65 years old is provided. The method comprising contacting the immune cells with an agent which increases the level of labile iron in the immune cells and/or reduces toxicity of hemoglobin, heme or a degradation product thereof, thereby increasing the proliferation of the adaptive immune cells of the subject.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL (USA)
Inventor
Kimmel, Ron
Groisser, Benjamin
Wolf, Alon
Widmann, Roger F.
Hillstrom, Howard J.
Abstract
A method comprising: receiving a radiographic image dataset representing a sequential radiographic scan of a region of a human subject; receiving three-dimensional (3D) image data representing an optical scan of a surface of said region, wherein said 3D image data is performed simultaneously with said sequential radiographic scan; estimating a time-dependent motion of said subject during said acquisition, relative to a specified position, based, at least in part, on said 3D image data; and using said estimating to determine corrections for said radiographic image dataset, based, at least in part, on a known transformation between corresponding coordinate systems of said radiographic image dataset and said 3D image data.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Geva-Zatorsky, Naama
Gefen, Tal
Kariti, Dana
Ben-Assa, Nadav
Abboud, Robert
Carasso, Shaqed
Zaatry, Rawan
Abstract
The present disclosure relates to the microbiome field. More specifically, the present disclosure relates to bacteriophages as a tool to manipulate gut immune-modulatory activity and uses thereof for therapy. More specifically, the present disclosure provides methods and tools for modulating an immune response in a subject in need thereof, by applying bacteriophage that modulates the phenotype of at least one bacteria in a subject.
Technion Research & Development Foundation Limited (Israel)
Inventor
Kvatinsky, Shahar
Wainstein, Nicolas
Yalon, Eilam
Abstract
An indirectly heated phase change switch (IPCS) for radio frequency (RF) switching, comprises two RF ports and an RF path therebetween, a phase change material (PCM) located between the RF ports, an embedded heater separated from the PCM by a dielectric layer, the embedded heater configured to provide thermal actuation of the PCM to bring about phase changes between a crystalline state and an amorphous state to provide Ohmic switching, and a bias voltage on the IPCS across said RF path. The bias is provided during heating to improve the crystallization time.
Technion Research & Development Foundation Limited (Israel)
Inventor
Melamed, Philippa
Polinsky, Lilach Pnueli
Abstract
Compositions and methods for treating a medical condition are provided. Accordingly, there is provided a composition comprising a polypeptide comprising a GnRH receptor binding protein and a polynucleotide coding a therapeutic agent, wherein said polypeptide is in association with said polynucleotide via a linker comprising a cleavage motif that can be cleaved by a proteolytic enzyme secreted by a cell expressing said GnRH receptor. Also provided is a nucleic acid construct comprising a nucleic acid sequence encoding a fusion protein comprising a DNA binding domain (DBD) of a transcription factor that binds a regulatory region of a gonadotropin gene attached to a chromatin modifying domain that represses transcription upon association with the DBD. Also provided are methods of use thereof.
Technion Research & Development Foundation Limited (Israel)
Inventor
Soljacic, Marin
Kaminer, Ido
Rivera, Nicholas
Sloan, Jamison
Salamin, Yannick
Abstract
A principle which enables the generation of macroscopic Fock and sub-Poissonian states is disclosed. Generic components of the system include: an electromagnetic structure (possessing one or more electromagnetic resonances), a nonlinear electromagnetic element (such as a nonlinear crystal near or inside the structure), and a source of light. In one embodiment, stimulated gain is used to create large numbers of photons in a cavity, but with very low photon number noise (uncertainty) in the cavity, and thus acts as a Fock laser. This Fock laser is capable of producing these states due to a very sharp intensity-dependent gain (or loss) that selects a particular photon number. The disclosed system and method are robust against both atomic and optical decoherence. Various examples of the new Fock laser design are also described.
C08J 11/12 - Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation by dry-heat treatment only
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
MIGAL GALILEE RESEARCH INSTITUTE LTD. (Israel)
Inventor
Geva-Zatorsky, Naama
Carasso, Shaqed
Gefen, Tal
Keshet, Roni
Hajjo, Haitham
Zaatry, Rawan
Sharon, Itai
Abstract
The present disclosure relates to reversible phase variations in bacteria e.g., residing in a microbiome or any environment, and uses thereof in determining a physiological and/or environmental condition or state of a subject or a media and/or or habitat. The present disclosure thus provides methods and personalized therapeutic methods and kits.
C12Q 1/04 - Determining presence or kind of microorganismUse of selective media for testing antibiotics or bacteriocidesCompositions containing a chemical indicator therefor
C12Q 1/02 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving viable microorganisms
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (USA)
Inventor
Kimmel, Ron
Groisser, Benjamin
Wolf, Alon
Widmann, Roger F.
Hillstrom, Howard J.
Abstract
A method comprising: generating a parametrized three-dimensional (3D) body surface model on a training set comprising a plurality of 3D scans of subjects, wherein at least some of said 3D scans are of subjects having a skeletal deformity; receiving one or more target 3D scans of a target subject; optimizing said body surface model with respect to said one or more target 3D scans to calculate a target body surface model of said target subject; training a skeletal estimation model on a training set comprising: (i) body surface models of a plurality of subjects, and (ii) skeletal landmarks sets of said plurality of subjects; and applying said trained skeletal estimation model to said calculated target body surface model of said target subject, to estimate a skeletal shape of said target subject.
Technion Research & Development Foundation Limited (Israel)
Inventor
Bohana-Kashtan, Osnat
Pinkas, Oded
Gotliv, Irina
Tsubery, Haim
Kopelman, Tal Yoetz
Chaim, Neta
Avni, Noa
Liandres, Hanna
Govrin, Roy
Malca, Yonatan
Machluf, Marcelle
Amsalem-Bergelson, Orit
Abstract
A method of producing spherical particles is provided herein. Also provided are compositions generated thereby and uses thereof in disease diagnosis and treatment.
Technion Research & Development Foundation Limited (Israel)
Inventor
Shechtman, Yoav
Ferdman, Boris
Opatovski, Nadav
Nehme, Elias
Kedem, Reut
Abstract
An objective lens system comprises a set of lenses, arranged along a common optical axis to form a back focal plane. The objective lens system also comprises an optical mask at the back focal plane, and a housing encapsulating the set of lenses and the optical mask.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Schroeder, Avi
Sela, Mor
Abstract
In one aspect of the invention, there is provided a nanoparticle comprising a core and a shell, wherein the core comprises a bioactive compound, and the shell comprises a lipid layer comprising a first modified lipid and a additional lipid, wherein the first modified lipid is bound to a targeted moiety via a spacer, and wherein the additional lipid comprises a polymer-bound lipid. The present invention further provides pharmaceutical compositions and methods for therapeutic and/or diagnostic use.
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
Technion Research & Development Foundation Limited (Israel)
Inventor
Hacohen-Gourgy, Shay
Diringer, Asaf A.
Abstract
A method for displacement of an electromagnetic mode (EM) conditioned on the state of an ancilla qubit, the method may include displacing, by applying a displacement operation, an EM mode whose frequencies are conditioned on the state of the ancilla qubit and are spaced apart by a frequency difference, by providing a displacement signal having a bandwidth that exceeds the frequency difference and has a zero amplitude at one or more of the frequencies of the electromagnetic mode which are defined by the displacement operation not to be displaced and a non-zero amplitude at one or more frequencies of the mode which are defined by the displacement operation to be displaced.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Shaked, Yuval Yechiel
Schroeder, Avi
Menachem, Rotem
Abstract
Nanoparticles comprising an outer surface covalently conjugated to 1,4-Bis[(1,4,8,11-tetraazacyclotetradecan-l-yl)methyl]benzene (AMD3100) or a derivative thereof capable of binding to C-X-C chemokine receptor type 4 (CXCR4) are provided. Methods for of treating a CXCR4 positive cancer, such as multiple myeloma or acute myeloid leukemia, in a subject in need thereof, methods of determining suitability for treatment and methods of covalently linking a molecule comprising a secondary amine to a lipid nanoparticle, are also provided.
A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
A61K 38/50 - Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
C07K 14/715 - ReceptorsCell surface antigensCell surface determinants for cytokinesReceptorsCell surface antigensCell surface determinants for lymphokinesReceptorsCell surface antigensCell surface determinants for interferons
A61K 31/255 - Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
A61K 31/565 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
A61K 31/00 - Medicinal preparations containing organic active ingredients
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
RAMBAM MED-TECH LTD, (Israel)
Inventor
Gepstein, Lior
Wexler, Yehuda
Abstract
Nucleic acid molecules comprising a first sequence encoding a cyclic nucleotide gated potassium channel or a functional fragment thereof and a second sequence encoding a chemogenetically activatable cyclic adenosine monophosphate (cAMP) generating receptor or a functional fragment thereof are provided. Expression vectors comprising the molecules, fusion proteins encoded by the molecules, cells, kits and pharmaceutical compositions are also provided. Methods of hyperpolarizing a cell, depolarizing a cardiac cell and treating a disease or condition are also provided.
C12N 15/62 - DNA sequences coding for fusion proteins
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
Technion Research & Development Foundation Limited (Israel)
Inventor
Bekenstein, Yehonadav
Strassberg, Rotem
Abstract
A method of fabricating a light emitting device, comprises mixing a first solution containing a polymeric component with a second solution containing quantum-confinement structures, to provide a solution mixture, and dispensing the solution mixture to form a fiber. The fiber is allow to be self-drawn such that at least one section of the fiber has a reduced diameter relative to another section.
H01L 33/56 - Materials, e.g. epoxy or silicone resin
B29C 64/118 - Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material using filamentary material being melted, e.g. fused deposition modelling [FDM]
B29K 27/12 - Use of polyvinylhalogenides as moulding material containing fluorine
B29K 33/00 - Use of polymers of unsaturated acids or derivatives thereof, as moulding material
B29K 105/00 - Condition, form or state of moulded material
D01F 6/12 - Monocomponent man-made filaments or the like of synthetic polymersManufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of halogenated hydrocarbons from polymers of fluorinated hydrocarbons
D01F 6/16 - Monocomponent man-made filaments or the like of synthetic polymersManufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Rotschild, Carmel
Cassell, Joseph
Abstract
An energy storage and retrieval system including an air chamber, a first air compressor operating with Heat Transfer Liquid (HTL-compressor) connected to the air chamber, a second turbine, operating with Heat Transfer Liquid (HTL-turbine) connected to the air chamber, accepting compressed air from the air chamber and producing work. Related apparatus and methods are also described.
H02K 7/18 - Structural association of electric generators with mechanical driving motors, e.g.with turbines
B01D 53/14 - Separation of gases or vapoursRecovering vapours of volatile solvents from gasesChemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases or aerosols by absorption
B01D 53/92 - Chemical or biological purification of waste gases of engine exhaust gases
F02C 6/18 - Plural gas-turbine plantsCombinations of gas-turbine plants with other apparatusAdaptations of gas-turbine plants for special use using the waste heat of gas-turbine plants outside the plants themselves, e.g. gas-turbine power heat plants
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Green, Dor
Schechter, Israel
Abstract
A method and system for detecting a state of an egg. Scan values are obtained for multiple scan locations on a shell of an egg, irradiation angles, and/or collection angles, at each the egg is irradiated and reflectance and/or emission is captured at a collection point and measured by a time¬ gated detector for one or more arrival times relative to an irradiation time. The scan values are analyzed to determine information of the egg's germinal disc and a state of the egg is determined according to the information.
G01N 21/25 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
G01N 21/31 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
G01N 21/63 - Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
G01N 21/17 - Systems in which incident light is modified in accordance with the properties of the material investigated
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Avital, Avraham
Brand, Zev
Abstract
Provided are methods for diagnosing or selecting a mammal in need of a stimulant ADHD drug, conducting a non-specific electro-dermal responses (EDAs) analysis and/or an auditory sustained attention (ASAT) analysis on the mammal and administering or adjusting the dose of a stimulant ADHD drug to be administered to the mammal.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Wolf, Alon
Zelnik-Manor, Lihi
Herbst, Yair
Chechik, Yoni
Abstract
A haptic feedback device is disclosed. The haptic feedback device may include at least one texture emulator; a housing at least partially containing the texture emulator; and a controller configured to: receive instructions to provide a texture sensation; and control the texture emulator to apply force to at least one location on a surface based on the received instructions.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Amdursky, Nadav
Kumar Sarkar, Amit
Abstract
A solid hydrogel material comprising a plant-based protein and the agent is provided, wherein the agent is selected from a carboxylic acid and glycol or combination thereof. Further, articles comprising the hydrogel of the invention are also provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Mizrahi, Boaz
Freundlich, Eden
Shimony, Neta
Abstract
A polymeric article comprising a plurality of convergent vertical structures bound to a support, wherein the article is composed of (i) a non-crosslinked biodegradable polymer, (ii) a crosslinked polymer, and (iii) a tissue-adhesive polymer, and use thereof such as for sealing a biological tissue is provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED. (Israel)
Inventor
Sprecher, Aaron
Nix, Tamar
Dahan, Yehiel
Abstract
A crocheting device is disclosed, configured to receive a continuous feed of textile material and produce therefrom a crochet structure. The device comprising a feed mechanism configured to receive a portion of the textile material and regulate tension thereof, a looping mechanism configured to draw tensioned textile material from the feed mechanism and form one or more loops therefrom, and a crocheting mechanism configured to receive the one or more loops from the looping mechanism and successively interlock them to one or more loops of the produced crochet structure.
D04B 35/16 - Indicating, warning, or safety devices, e.g. stop motions responsive to thread breakage with detectors associated with a series of threads
58.
METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Amit, Roee
Goldberg, Sarah
Granik, Naor
Kikuchi, Nanami
Willinger, Or
Kitchen, Patricia
Abstract
RNA-protein granules comprising fusion proteins and RNA are disclosed, as well as uses thereof for treating or preventing viral infection. Soluble fusion proteins comprising an extracellular domain of a human receptor or a fragment thereof and a bacteriophage coat protein, as well as synthetic microcarriers comprising a solid support conjugated to a plurality of viral proteins or fragments thereof are provided. Nucleic acid molecules and vectors encoding the soluble fusion protein, synthetic RNA-protein granules comprising a fusion protein, as well as method using the soluble fusion protein are also provided.
Technion Research & Development Foundation Limited (Israel)
Inventor
Freiman, Mordechay Pinchas
Nemirovsky-Rotman, Shira
Abstract
A method for estimating parameters of a model that is non-linear and is more complex than a log-linear model, the method may include feeding measured observations and sampling coordinates of the measured observations to a machine learning process; and processing the measured observations and the sampling coordinates of the measured observations, by the machine learning process, to provide an estimate of the parameters of the model; wherein the model is indicative of a relationship between the measured observations and the sampling coordinates.
Technion Research & Development Foundation Limited (Israel)
Inventor
Machluf, Marcelle
Fishman, Ayelet
Davidovich-Pinhas, Maya
Baruch, Limor
Zernov, Anton
Glusac, Jovana
Abstract
Compositions-of-matter containing a plurality of edible microstructures (e.g., microparticles) made of a plant protein extract, composites containing such compositions-of-matter and cells adhered to the microstructures, and processes of preparing same, are provided. Also provided are food products containing these composites and methods of preparing same.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Rotschild, Carmel
Cassell, Joseph
Abstract
A method for converting heat to mechanical work includes providing incoming heat transfer liquid (HTL) at a first temperature to a plurality of mixing chambers, providing incoming compressed gas at a second temperature to the plurality of mixing chamber, enabling the gas and the HTL to mix, producing a gas-and-HTL mix, enabling the HTL in the gas-and-HTL mix to heat the gas and isothermal expansion of the gas in the gas-and-HTL mix, limiting volume of the gas-and-HTL mix, thereby increasing pressure of the gas and causing acceleration of a flow of the gas-and-HTL mix, causing the gas-and-HTL mix to eject through a plurality of nozzles, thereby converting the heat of the HTL to kinetic energy to cause movement of the plurality of nozzles; and using the kinetic energy to produce mechanical work.
F01K 27/00 - Plants for converting heat or fluid energy into mechanical energy, not otherwise provided for
F01K 21/04 - Steam engine plants not otherwise provided for using mixtures of steam and gasPlants generating or heating steam by bringing water or steam into direct contact with hot gas
F01K 25/06 - Plants or engines characterised by use of special working fluids, not otherwise provided forPlants operating in closed cycles and not otherwise provided for using mixtures of different fluids
62.
COMPACT ROBOTIC DEVICE AND ASSEMBLIES FOR MANIPULATION OF ELONGATE SURGICAL TOOLS
Technion Research & Development Foundation Limited (Israel)
Inventor
Sharon, Simon
Boader, Idan
Kofman, Evgeny
Sohn, Zev
Shoham, Moshe
Cohen, Eran
Morag, Eyal
Abstract
An assembly for driving movement of an elongate surgical tool, comprising:
An assembly for driving movement of an elongate surgical tool, comprising:
a plurality of adjacent pairs of driving wheels, each pair of driving wheels having a space therebetween such that spaces of the plurality of pairs of driving wheels are axially aligned to form a channel for the elongate surgical tool to extend through;
wherein at least one pair of driving wheels out of the plurality of pairs is arranged to lie on a plane different than a plane on which at least one other pair of driving wheels lies.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
YEDA RESEARCH AND DEVELOPMENT CO. LTD. (Israel)
Inventor
Schroeder, Avraham
Abel, Ravit
Eldar, Yonina
Eder, Yonathan
Abstract
A system and method is presented for imaging a biological tissue, marked by metal particles, in at least one region of interest in the biological tissue. The system comprises: a frequency modulated continuous wave (FMCW) transceiver system comprising at least one radiation transmitter and at least one radiation receiver, the FMCW transceiver being configured to transmit series of millimeter wavelength signals to interact with each of said at least one region of interest and receive radiation originated within a field of view of the transceiver, and generate raw measured data indicative of received radiation; and a control system configured and operable to receive and process said raw measured data, the processing comprising extracting from said raw measured data, data indicative of radiation response of said metal particles to said interaction with the millimeter wavelength signals for each of said at least one region of interest, and determining map data indicative of a distribution of said metal particles within each region of interest.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Meller, Amit
Marom, Yulia
Chandra Verma, Navneet
Abstract
Systems for detecting fluorescence from a molecule comprising an ion-impermeable film comprising at least one ion-conducting nanopore and a laser coupling slot; a first and second liquid reservoir separated by the film; a means to induce movement of the molecule from the first reservoir to the second reservoir via the nanopore; a light source capable of exciting the molecule to emit fluorescence, wherein the light source shines into the second reservoir; a metallic layer adhered to the film by an adhesion layer and comprising a nanowell structure located adjacent to the nanopore; and a detector configured to detect the fluorescence emitted by the molecule are provided. Methods of use of the systems are also provided.
G01N 21/63 - Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
G01N 33/487 - Physical analysis of biological material of liquid biological material
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Meller, Amit
Ohayon, Shilo
Taib, Liran
Abstract
Methods of determining the identity of a protein of interest within a sample comprising running the sample through a porous media within a nanochannel, determining a dynamic trajectory of the protein of interest as it moves through the porous media, measuring abundance of at least one amino acid in the protein and determining the protein's identity based on the abundance of the amino acid and at least one parameter calculated from the dynamic trajectory; are provided. Methods of detecting a protein in a stream of images taken of a porous media in a nanochannel are also provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Agnon, Yehuda
Ramon, Guy
Meir, Avishai
Abstract
A thermoacoustic device that includes a resonator, wherein the resonator includes a stack. During operation, a cold zone of the stack is configured to receive at least one fluid from a hot zone of the stack; wherein a temperature of the hot zone exceeds a temperature of the cold zone. The thermoacoustic device also includes a conveyor for conveying at least some of the at least one fluid from the cold zone of the stack to the hot zone of the stack.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Meiri, Dedi
Fuchs, Yaron
Koren, Elle
Sedov, Egor
Abstract
The present invention provides a pharmaceutical composition including a combination of one or more cannabinoids, and a methods of using same, such as for treating any one of: a wound, regenerating skin, alopecia, an inflammatory skin disease, a sebaceous gland proliferative disease, and any disorder, condition, or symptom associated therewith.
Technion Research & Development Foundation Limited (Israel)
Inventor
Nazarathy, Moshe
Kodanev, Anna
Abstract
An optical frequency sensor that includes (i) a heterodyne modulation and splitting unit that is configured to receive a first laser signal, modulate the first laser signal to provide a modulated laser signal and split the modulated laser signal to provide pre-processed optical signals; (ii) a self-coherent interferometer that includes (ii.1) a first optical processor that is configured to process the pre-processed optical signals to provide processed optical signals, and (ii.2) a detection unit that is configured to electro-optically mix the processed optical signals and photodetect an outcome of the mixing to provide detection signalsm and (iii) a signal processor configured to process the one or more digital signals to provide digital information about the first laser signal.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Dahan, Raphael
Kaminer, Ido
Yannai, Michael
Fishman, Tal
Abstract
A charged particles beam column for inspecting a sample in a sample plane is presented. The charged particles beam column comprises: a charged particles source generating a charged particles beam propagating along a general propagation path towards the sample plane; and at least one charged particles beam shaping unit. The charged particles shaping unit comprises at least one high-frequency electromagnetic radiation generator located in a vicinity of said general propagation path of the charged particles beam and controllably operated to perform synchronized generation of said high-frequency electromagnetic radiation towards at least one interaction region in said general propagation path, to cause interaction between said radiation and the charged particles, thereby directly affecting energy properties of the charged particles passing through said at least one interaction region in the general propagation path and directly affecting spectral resolution of the charged particles beam at said sample plane.
Technion Research & Development Foundation Limited (Israel)
Inventor
Ein-Eli, Yair
Amdursky, Nadav
Abstract
The present invention discloses a slurry for electrode preparation, relevant to the field of electrode fabrication for various applications, which consists of an active material, a conductive additive, and a binder composition that includes a proteinaceous substance that may comprise amino acids, peptides, and/or proteins. The instantly disclosed slurry is useful in electrode fabrication, especially in the context of Li batteries. The process for preparing the electrode includes applying the slurry to a current collector and thermally treating the slurry, ensuring a durable and reliable electrode.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Sagi, Roy
Schlagman, Zohar
Abstract
The present invention provides kits and compositions for e.g., hypergolic ignition of rocket propellant. The disclosed kits and the compositions comprise inter alia a fuel, a gelling agent, and an ignition agent; wherein the ignition agent is stably dissolved within the fuel.
C06B 27/00 - Compositions containing a metal, boron, silicon, selenium or tellurium or mixtures, intercompounds or hydrides thereof, and hydrocarbons or halogenated hydrocarbons
C06B 23/00 - Compositions characterised by non-explosive or non-thermic constituents
C06B 47/02 - Compositions in which the components are separately stored until the moment of burning or explosion, e.g. "Sprengel"-type explosivesSuspensions of solid component in a normally non-explosive liquid phase, including a thickened aqueous phase the components comprising a binary propellant
72.
MODULATORS OF PROTEASOME DYNAMICS AND/OR FUNCTION, COMPOSITIONS, METHODS, AND THERAPEUTIC USES THEREOF
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Ciechanover, Aaron
Livneh, Ido
Cohen-Kaplan, Victoria
Fabre, Bertrand Francois
Abstract
The present disclosure provides modulators of proteasome dynamics and/or function in a mammalian cell, compositions and uses thereof. The disclosed modulating compounds are characterized by affecting at least one of: mammalian target of rapamycin (mTOR) activation and/or lysosomal association, proteasome cellular localization, the activity and/or level/s and/or the post translational modification/s (PTM/s), and/or subcellular localization of at least one signaling molecule participating directly or indirectly in at least one pathway mediating said proteasome dynamics/function.
Technion Research & Development Foundation Limited (Israel)
Inventor
Koren, Elad
Dutta, Debopriya
Mukherjee, Subhrajit
Abstract
A heterostructure system comprises a two-dimensional ferroelectric material on a dielectric substrate, and a two-dimensional semiconductor material having a first region disposed on the ferroelectric material and a second region disposed on the dielectric substrate, wherein an edge of the ferroelectric material is between the first region and the second region of the semiconductor material.
H01L 31/113 - Devices sensitive to infrared, visible or ultraviolet radiation characterised by field-effect operation, e.g. junction field-effect photo- transistor being of the conductor-insulator- semiconductor type, e.g. metal- insulator-semiconductor field-effect transistor
H01L 31/032 - Inorganic materials including, apart from doping materials or other impurities, only compounds not provided for in groups
H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Assaraf, Yehuda G.
Livney, Yoav D.
Cohen, Lital
Abstract
This invention, in some embodiments thereof, provides a core-shell nanoparticle including a lipid-PSMA conjugate, encapsulating a liquid oil-based core. The invention further provides aqueous compositions including the core-shell nanoparticles, and methods for using same, such as for the treatment of proliferative diseases associated with PSMA upregulated expression.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Rotschild, Carmel
Abstract
A system permitting efficient heat pump, storage of thermal energy, and retrieval of this stored thermal energy back to electricity upon demand. The system operates in two operational modes: a charging operational mode, in which thermal energy is pumped in an electrically driven compressor and is transferred into a hot heat transfer liquid reservoir by a heat transfer liquid; and a discharging operational mode, in which thermal energy from the hot reservoir is utilized in a turbine to produce kinetic energy that can be used directly or can be converted into an electric energy to be used when desired.
F01K 21/02 - Steam engine plants not otherwise provided for with steam generation in engine cylinders
F01K 25/06 - Plants or engines characterised by use of special working fluids, not otherwise provided forPlants operating in closed cycles and not otherwise provided for using mixtures of different fluids
76.
TRANSLOCATOR PROTEIN LIGANDS AND INFLAMMATORY DISEASES
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Gavish, Moshe
Abstract
Methods for treating or reducing inflammation, in is in a site or an organ excluding the central nervous system of a subject in need thereof, by administering a pharmaceutical composition comprising the translocator protein ligand 2-C1-MGV-1, are provided.
A61K 31/517 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
C07D 239/91 - Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Technion Research & Development Foundation Limited (Israel)
Inventor
Pokroy, Boaz
Polishchuk, Iryna
Prudnikov, Elena
Segal, Ester
Abstract
A process of depositing a hydrophobic or superhydrophobic film on a surface of a substrate, effected by spraying onto the substrate's surface a solution comprising a fatty acid and an organic solvent, is provided. Substrates and articles-of-manufacturing containing the substrates, having a hydrophobic or superhydrophobic coating/film deposited thereon, obtainable or prepared by the process, are also provided. The process is usable for reducing a load of a pathogenic microorganism and/or for preventing biofilm formation on and/or in the substrates or articles-of-manufacturing containing same.
B05D 5/08 - Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
A23P 20/10 - Coating with edible coatings, e.g. with oils or fats
B05D 1/02 - Processes for applying liquids or other fluent materials performed by spraying
C09D 5/14 - Paints containing biocides, e.g. fungicides, insecticides or pesticides
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Oryan (orian), Amir
Brik, Ashraf
Abu Ahmad, Yamen
Gandhesiri, Satish
Abstract
The present invention provides compounds and pharmaceutical compositions comprising thereof. Further, methods for treating or preventing development of a RNF4 related disorder in a subject in need thereof are also provided.
C07D 417/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Technion Research & Development Foundation Limited (Israel)
Inventor
Bronstein, Alexander
Weiss, Tomer
Peretz, Nissim
Vedula, Sanketh
Feuer, Arie
Abstract
A method of designing a radar, comprises receiving data pertaining to a set of reflected signals received from a distribution of objects by a respective set of receiving antennas at a respective set of locations, and feeding the data and the locations as training data to a machine learning procedure. The machine learning procedure calculates, simultaneously, a set of learned antenna locations and a set of learned parameters associating the signals with the objects, thereby providing a trained machine learning procedure parametrized by the set of learned parameters.
G01S 7/41 - Details of systems according to groups , , of systems according to group using analysis of echo signal for target characterisationTarget signatureTarget cross-section
Technion Research & Development Foundation Limited (Israel)
Inventor
Diesendruck, Charles Eliezer
Dekel, Dario R.
Abstract
Polymeric ion conductors composed of a polymeric matrix associated with an isoindolinium moiety represented by Formula I as described in the specification are provided. Anion conducting compositions comprising an anion conducting polymer associated with, or threaded within and having mechanically interlocked therearound, a cyclic moiety are also provided. lonomeric materials, including, for example, ion exchange membranes such as anion exchange membranes, made of the polymeric ion conductor and/or the anion conducting composition, and electrochemical systems and articles-of-manufacturing containing the polymeric ion conductor, the anion conducting composition or the ion exchange membrane are also provided.
B01J 41/14 - Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
B01J 41/05 - Processes using organic exchangers in the strongly basic form
B01J 47/12 - Ion-exchange processes in generalApparatus therefor characterised by the use of ion-exchange material in the form of ribbons, filaments, fibres or sheets, e.g. membranes
H01M 8/103 - Polymeric electrolyte materials characterised by the chemical structure of the main chain of the ion-conducting polymer having nitrogen, e.g. sulfonated polybenzimidazoles [S-PBI], polybenzimidazoles with phosphoric acid, sulfonated polyamides [S-PA] or sulfonated polyphosphazenes [S-PPh]
Technion Research & Development Foundation Limited (Israel)
Inventor
Shechtman, Yoav
Opatovski, Nadav
Abstract
In a range imaging system, a passive optical system has a set of lenses and an optical mask that varies a point spread function of the set of lenses so as to encode in an optical field arriving from a scene range information for objects in the scene that are at least X meters from the mask, where X is at least 10. A digital light sensor receives the optical field, and an image processor processes signals receive signals from the sensor to decode the range information.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
RAMBAM MED-TECH LTD. (Israel)
Inventor
Ciechanover, Aaron
Golts, Alona
Livneh, Ido
Zohar, Yaniv
Elad, Michael
Abstract
The present disclosure is related to the field of machine learning (ML) based detection and classification. More specifically, the present disclosure provides computer implemented methods of detection and multi-class classification of objects of interest in an image, computer program product operable in a computer, and diagnostic methods thereof.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
RAMBAM MED-TECH LTD. (Israel)
Inventor
Shen-Orr, Shai
Chowers, Yehuda
Gerassy-Vainberg, Shiran
Blatt, Alexandra
Starovetsky, Elina
Gaujoux, Renaud Gilles
Maimon, Naama
Abstract
The present invention is directed to a kit and a method for determining the suitability of a subject to a treatment using a tumor necrosis factor alpha (TNFα). Further provided is a method for treating the subject determined to be suitable for a treatment using a TNFα inhibitor.
C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
C07K 16/24 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
G01N 33/564 - ImmunoassayBiospecific binding assayMaterials therefor for pre-existing immune complex or autoimmune disease
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Samish, Ilan
Zuker, Inbar
Marko, Shmuel
Livney, Yoav
Goldman, Evgeniya
Edelman, Ravit
Pawar, Prerna Balkrishna
Alasibi, Samaa
Abstract
The present invention relates to functional taste-improving composition comprising at least one taste-modifying protein (TMP), e.g., a sweet protein (SP) and at least one micropatching (MP) agent; and to uses thereof in the food and beverage industry.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Yelin, Dvir
Fridman, Lidan
Abstract
A method of image enhancement of a reflectance confocal microscope is disclosed. The method comprises: receiving by a processor a first image captured by a detector of the confocal microscope, at a first position of a pinhole; receiving one or more second images captured by the detector, at at least one second position of the pinhole; and adding, by the processor, the one or more second images to the first image to reduce a speckle contrast in the combined image. In addition, the first position of the pinhole is a confocal position, and the at least one second position is a shifted position with respect to the confocal position.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Rotschild, Carmel
Cassell, Joseph
Neumann, Yuval
Abstract
The present disclosure provides a novel configuration of a fluid pressurization nozzle which is relatively simple in its mechanical design for attaining an isothermal or quasi-isothermal pressurization process of fluid, e.g., isothermal or quasi-isothermal compression of gas. The fluid pressurization nozzle of the present disclosure utilizes the general principles of an expanding-contracting nozzle (e.g., Venturi nozzle), which is modified for eliminating or significantly attenuating generation of shock waves in the nozzle to thereby facilitate efficient compression of the gas. The fluid pressurization nozzle of the present disclosure has a profile defining a varying cross-section along a length thereof. As such, the fluid pressurization nozzle is configured for affecting / manipulating characteristics / properties of fluid(s) propagating therealong. Such properties can include, inter alia, pressure, Mach number, velocity, and temperature. Optionally, and in some embodiments preferably, the fluid compression nozzle of the present disclosure is configured to pressurize suction fluid (e.g., gas) introduced thereinto, with the aid of a heat transfer liquid (HTL) propagating / flowing therealong. The introduced suction fluid is mixed with the HTL to form a liquid/gas mixture in which the gas is pressurized.
F04F 5/04 - Jet pumps, i.e. devices in which fluid flow is induced by pressure drop caused by velocity of another fluid flow the inducing fluid being liquid displacing elastic fluids
Technion Research & Development Foundation Limited (Israel)
BAR-ILAN UNIVERSITY (Israel)
Inventor
Bar-Lev, Daniella
Orr, Itai
Sabary, Omer
Etzion, Tuvi
Yaakobi, Eitan
Abstract
A method for estimating an information unit represented by DNA strands, the method includes (a) sequencing the DNA strands to provide noisy copies of an encoded version of the information unit; wherein the information unit comprises information unit elements; (b) neural network (NN) processing the multiple noisy copies by one or more NNs to provide a soft estimate of the encoded information unit; wherein the soft estimate comprises estimated encoded information unit elements and an encoded information unit elements estimated confidence parameter; and (c) decoding the soft estimate of the encoded information unit to provide a prediction of the information unit.
G06F 30/27 - Design optimisation, verification or simulation using machine learning, e.g. artificial intelligence, neural networks, support vector machines [SVM] or training a model
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Health Corporation Of Tzafon Medical Center (R.A.) (Israel)
Inventor
Bianco-Peled, Havazelet
Schroeder, Avi
Abu El-Naaj, Imad
Habib, Layan
Alyan, Mohammed
Ghantous, Yasmin
Abstract
A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a dry hybrid system, composed of bio adhesive polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents or biological agents, is provided.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
RAMOT AT TEL-AVIV UNIVERSITY LTD. (Israel)
Inventor
Wolf, Alon
Gefen, Amit
Shaulian, Hadar
Abstract
A foot support structure having: a foot support surface for engagement by a foot of a subject; and a tissue loading alleviation zone within the foot support surface, such that the tissue loading alleviation zone defines a region of the foot support surface configured for optimizing an internal tissue loading state in a volume-of-interest (VOI) in said foot of said subject, and the region has at least one mechanical property value that gradually varies along at least one dimension of the region.
A43B 7/1455 - Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
A43B 7/144 - Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the heel, i.e. the calcaneus bone
A61B 5/103 - Measuring devices for testing the shape, pattern, size or movement of the body or parts thereof, for diagnostic purposes
90.
RNAI NANOPARTICLES AND METHODS OF USING SAME IN AGRICULTURE
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israel)
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Shoseyov, Oded
Schroeder, Avi
Avital, Aviram
Sadot Muzika, Noy
Persky, Zohar Lily
Abstract
The present invention provides a nanoparticle including: (a) an amphiphilic co-polymer including an ionizable polymer covalently bound to a hydrophobic domain; and a polynucleotide comprising 60 to 500 nucleobases. Further provided are compositions including the nanoparticle of the invention, and methods of using same.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD (Israel)
Inventor
Gross, Zeev
Mahammed, Atif
Abstract
Embodiments of the invention relate to a corrole according to formula [I]; wherein R1, R2, and R3 are each independently H, —COOH, CF3, or a halide selected from the group consisting of F—, Cl—, Br— and I, with the proviso that R1, R2, and R3 can not all be CF3, and when the compound is of Formula II, wherein M is a metallic ion or an elemental ion selected from the group consisting of an elemental ion of group 13-16 in row 3 or above and boron, preferably selected from the group consisting of: Fe, Mn, Ga, P, Mo, Re, Co and Cu, or a salt thereof. Methods for treatment, catalysis, and detection using the compounds are also described.
C07F 5/00 - Compounds containing elements of Groups 3 or 13 of the Periodic Table
B01J 31/18 - Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony
B01J 35/00 - Catalysts, in general, characterised by their form or physical properties
C07D 487/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains four or more hetero rings
C07F 13/00 - Compounds containing elements of Groups 7 or 17 of the Periodic Table
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Blanc, Nathan
Ramon, Guy
Agnon, Yehuda
Meir, Avishai
Abstract
A thermoacoustic engine that consists essentially of: a heat exchanger; and a resonator that is in communication with the heat exchanger. The resonator includes a media configured to absorb one or more electromagnetic signals. The thermoacoustic engine is configured to receive the one or more electromagnetic signals and generate acoustic power.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Shamay, Yosi
Harris, Yuval
Niezni, Danna
Sason, Hagit
Abstract
The present invention relates to a composition comprising a mixture of oligomers or co-oligomers obtained by exposing an indolium-based monomer, optionally together with an additional monomer selected from dopamine, L-dopa, norepinephrine, serotonin, and a mixture thereof, to a basic buffer. The composition disclosed may further comprise a hydrophobic substance such as a drug or dietary supplement, stabilized by said oligomers above.
Technion Research & Development Foundation Limited (Israel)
Inventor
Diesendruck, Charles Eliezer
Dekel, Dario R.
Abstract
Polymeric ion conductors composed of a polymeric or co-polymeric backbone which comprises a plurality of backbone units, a metal ligand attached to at least a portion of the backbone units, and a metal ion attached to the metal ligand are provided. The metal ligand can be an N-heterocyclic carbene ligand and the metal can feature low oxophilicity. lonomeric materials, including, for example, ion exchange membranes such as anion exchange membranes, made of the polymeric ion conductor, and electrochemical systems and articles-of-manufacturing containing the polymeric ion conductor or the ion exchange membrane are also provided.
H01M 8/1023 - Polymeric electrolyte materials characterised by the chemical structure of the main chain of the ion-conducting polymer having only carbon, e.g. polyarylenes, polystyrenes or polybutadiene-styrenes
H01M 8/1067 - Polymeric electrolyte materials characterised by their physical properties, e.g. porosity, ionic conductivity or thickness
95.
AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE
Technion Research & Development Foundation Limited (Israel)
Tel HaShomer Medical Research Infrastructure and Services Ltd. (Israel)
Inventor
Levenberg, Shulamit
Landau, Shira
Duvdevani, Shay
Abstract
An aspect of some embodiments of the invention relates to methods of manufacturing a 3D printed implant, comprising printing a mold of a scaffold, generating said scaffold from said mold, seeding cells on said scaffold, where said generating said scaffold comprises generating parts of said scaffold with different levels of stiffness.
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Meiri, David
Wyrobnik, Iris
Novak Kotzer, Hila
Steinberg, Miryam
Gelfand, Anat
Procaccia, Shiri
Abstract
The present invention provides a pharmaceutical composition including cannabigerol, and methods of using same, such as for increasing therapeutic efficacy of an immune checkpoint inhibitor, or for the treatment of cancer.
Technion Research & Development Foundation Limited (Israel)
Inventor
Freiman, Mordechay Pinchas
Avidan, Nitzan
Abstract
A method for reconstructing spatial information, the method includes: (i) Obtaining an under-sampled frequency domain representation (FDR) of the spatial information. The under-sampled FDR was obtained by sampling an FDR of the spatial information with a sampling mask. (ii) Feeding the under-sampled FDR and the sampling mask to a machine learning process. (iii) Reconstructing the spatial information by the machine learning process. The machine learning process was trained using a training data set that includes training under-sampled FRDs of training spatial information, and one or more training sampling masks that were used to sample FDRs of training spatial information.
A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Meir, Avishai
Agnon, Yehuda
Ramon, Guy
Blanc, Nathan
Cassell, Joseph
Abstract
A pump system wherein a pressure storage unit configured to receive input pressure for build-up of pressurized gaseous material thereinside and communicate the same to a pumping unit at least partially submerged in a body-of-liquid. The pumping unit comprises an internal liquid passage extending upwardly a certain length from a bottom opening thereof, a discharge tube at least partially accommodating by a bottom end potion thereof a portion of the internal liquid passage, a gas -liquid vessel in fluid communication with the discharge tube and configured to receive via an upper portion thereof pressurized gaseous material from the pressure storage unit, to thereby lift a certain amount of liquid towards a liquid outlet of the discharge tube.
E21B 43/12 - Methods or apparatus for controlling the flow of the obtained fluid to or in wells
F04B 47/08 - Pumps or pumping installations specially adapted for raising fluids from great depths, e.g. well pumps having motor-pump units situated at great depth the motors being actuated by fluid
F04F 1/08 - Pumps using positively or negatively pressurised fluid medium acting directly on the liquid to be pumped the fluid medium acting on the surface of the liquid to be pumped specially adapted for raising liquids from great depths, e.g. in wells
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Hasson, Peleg
Wolfenson, Haguy
Melamed, Shay
Eilot, Shelly
Boger, Elisabeth
Aviram, Rohtem
Abstract
An isolated peptide comprising an amino acid sequence of a lysyl oxidase (LOX) family member target site of an extracellular matrix protein, the peptide being no longer than 50 amino acids, for use in treating a disease associated with fibrosis in a subject in need thereof.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61P 43/00 - Drugs for specific purposes, not provided for in groups
100.
SYSTEM AND METHOD OF TRAINING A NEURAL NETWORK MODEL
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (Israel)
Inventor
Gilboa, Guy
Turjeman, Rotem
Berkov, Tom
Cohen, Ido
Abstract
A method and system for implementing a machine-learning (ML) based function may include providing a NN model comprising a plurality of NN parameters; training the NN model over a plurality of training epochs, to implement a predefined ML function, based on a training dataset; for one or more NN parameters of the plurality of NN parameters: (i) calculating a profile vector, representing evolution of the NN parameter through the plurality of training epochs; and (ii) calculating an approximated value of the at least one NN parameter, based on the profile vector; and replacing at least one NN parameter value in the trained NN model with a respective calculated approximated value, to obtain an approximated version of the trained NN model.